1887

Chapter 6 : Human Interventions on the Evolution of Host-Bacterium Interactions

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Human Interventions on the Evolution of Host-Bacterium Interactions, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap06-2.gif

Abstract:

Bacterial infections pose a serious threat to human health; antibiotics are a powerful remedy. This chapter discusses the biological background for the evolution of antibiotic resistance and reviews some of the possible ways that humans can intervene. It focuses on a priori justification for the interventions, the difficulties in implementing them, and some evidence for their success. The problem of resistance to antibiotics in bacteria spans many academic disciplines, including ecology, microbiology, medicine, nursing, bacterial genetics, evolutionary biology, economics, statistics, and mathematics. Colonization and infection define the ecological and epidemiological background for the evolution of antibiotic resistance. The evolution of antibiotic resistance involves two processes: emergence and spread. Thresholds may be most important as motivating concepts for understanding the dynamics and control of antibiotic resistance. The chapter examines the way antibiotics are typically used and strategies for reducing use or manipulating antibiotic use to reduce the spread of resistance. The use of antibiotics is a major perturbation to microbial communities. The evolution of resistance has economic causes as well as biological ones. Sufficient investment in the types of solutions discussed here, and research to support their use could reduce resistance, but without an understanding of the current incentives and without structural changes, these solutions are not likely to reverse current trends.

Citation: Smith D, Laxminarayan R. 2008. Human Interventions on the Evolution of Host-Bacterium Interactions, p 51-62. In Baquero F, Nombela C, Cassell G, Gutiérrez-Fuentes J (ed), Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC. doi: 10.1128/9781555815639.ch6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815639.ch06
1. Aarestrup, F. M.,, F. Bager,, N. E. Jensen,, M. Madsen,, A. Meyling, and, H. C. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS 106:606622.
2. Andersson, D. I., and, B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489493.
3. Antia, R.,, R. R. Regoes,, J. C. Koella, and, C. T. Bergstrom. 2003. The role of evolution in the emergence of infectious diseases. Nature 426:658661.
4. Austin, D. J., and, R. M. Anderson. 1999. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philos. Trans. R. Soc. London B 354:721738.
5. Austin, D. J.,, M. Kakehashi, and, R. M. Anderson. 1997. The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc. Biol. Sci. 264:16291638.
6. Austin, D. J.,, M. J. Bonten,, R. A. Weinstein,, S. Slaughter, and, R. M. Anderson. 1999a. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl. Acad. Sci. USA 96:69086913.
7. Austin, D. J.,, K. G. Kristinsson, and, R. M. Anderson. 1999b. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl. Acad. Sci. USA 96:11521156.
8. Baden, L. R.,, W. Thiemke,, A. Skolnik,, R. Chambers,, J. Strymish,, H. S. Gold,, R. C. Moellering, Jr., and, G. M. Eliopoulos. 2001. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of “clearance.” Clin. Infect. Dis. 33:16541660.
9. Bergstrom, C. T.,, M. Lo, and, M. Lipsitch. 2004. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc. Natl. Acad. Sci. USA 101:1328513290.
10. Blatnik, J., and, G. Lesnicar. 2006. Propagation of methicillin-resistant Staphylococcus aureus due to the overloading of medical nurses in intensive care units. J. Hosp. Infect. 63:162166.
11. Bonhoeffer, S.,, M. Lipsitch, and, B. R. Levin. 1997. Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl. Acad. Sci. USA 94:1210612111.
12. Bonten, M. J.,, D. J. Austin, and, M. Lipsitch. 2001. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin. Infect. Dis. 33:17391746.
13. Bonten, M. J.,, S. Slaughter,, A. W. Ambergen,, M. K. Hayden,, J. van Voorhis,, C. Nathan, and, R. A. Weinstein. 1998. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch. Intern. Med. 158:11271132.
14. Boyce, J. M. 2001. MRSA patients: proven methods to treat colonization and infection. J. Hosp. Infect. 48(Suppl A): S9S14.
15. Carbon, C. 1999. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 44(Suppl A): 3136.
16. Carmeli, Y.,, G. M. Eliopoulos, and, M. H. Samore. 2002. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg. Infect. Dis. 8:802807.
17. Creedon, S. A. 2005. Healthcare workers’ hand decontamination practices: compliance with recommended guidelines. J. Adv. Nurs. 51:208216.
18. Dall’Antonia, M.,, P. G. Coen,, M. Wilks,, A. Whiley, and, M. Millar. 2005. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J. Hosp. Infect. 61:6267.
19. Davis, K. A.,, J. J. Stewart,, H. K. Crouch,, C. E. Florez, and, D. R. Hospenthal. 2004. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 39:776782.
20. Donskey, C. J. 2004. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39:219226.
21. Dowell, S. F., and, B. Schwartz. 1997. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am. Fam. Physician 55:16471654, 16571658.
22. Edwards, M.,, J. Dennison, and, P. Sedgwick. 2003. Patients’ responses to delayed antibiotic prescription for acute upper respiratory tract infections. Br. J. Gen. Pract. 53:845850.
23. Ellison, R. T., III. 2006. Review: probiotics are effective for prevention of antibiotic-associated diarrhea and treatment of Clostridium difficile disease. ACP J. Club. 145:46.
24. Fagon, J. Y.,, J. Chastre,, M. Wolff,, C. Gervais,, S. Parer-Aubas,, F. Stephan,, T. Similowski,, A. Mercat,, J. L. Diehl,, J. P. Sollet, and, A. Tenaillon. 2000. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med. 132:621630.
25. Foster, K. R., and, H. Grundmann. 2006. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med. 3:e29.
26. Furuno, J. P.,, J. C. McGregor,, A. D. Harris,, J. A. Johnson,, J. K. Johnson,, P. Langenberg,, R. A. Venezia,, J. Finkelstein,, D. L. Smith,, S. M. Strauss, and, E. N. Perencevich. 2006. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch. Intern. Med. 166:580585.
27. Hardin, G. 1968. The tragedy of the commons. Science 162:12431248.
28. Hartley, D. M.,, J. P. Furuno,, M. O. Wright,, D. L. Smith, and, E. N. Perencevich. 2006. The role of institutional epidemiologic weight in guiding infection surveillance and control in community and hospital populations. Infect. Control Hosp. Epidemiol. 27:170174.
29. Hayden, M. K.,, M. J. Bonten,, D. W. Blom,, E. A. Lyle,, D. A. van de Vijver, and, R. A. Weinstein. 2006. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin. Infect. Dis. 42:15521560.
30. HICPAC. 1995. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am. J. Infect. Control 23:8794.
31. Hummel, R.,, H. Tschape, and, W. Witte. 1986. Spread of plasmid-mediated nourseothricin resistance due to antibiotic use in animal husbandry. J. Basic Microbiol. 26:461466.
32. Krause, R. M. 2002. Evolving microbes and re-emerging streptococcal disease. Clin. Lab. Med. 22:835848.
33. Kummerer, K. 2004. Resistance in the environment. J. Antimicrob. Chemother. 54:311320.
34. Laxminarayan, R., and, D. L. Smith. 2006. Ecology and economics of cycling antibiotics: insights from mathematical modeling p. 169180. In C. A. Cuevas (ed), Multiple Drug Resistant Bacteria, 2nd ed. Horizon Scientific Press, Norwich, United Kingdom.
35. Levin, B. R. 2001. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 33(Suppl 3): S161S169.
36. Levin, B. R., and, C. T. Bergstrom. 2000. Bacteria are different: observations, interpretations, speculations, and opinions about the mechanisms of adaptive evolution in prokaryotes. Proc. Natl. Acad. Sci. USA 97:69816985.
37. Levin, B. R.,, V. Perrot, and, N. Walker. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985997.
38. Lipsitch, M.,, C. T. Bergstrom, and, B. R. Levin. 2000. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl. Acad. Sci. USA 97:19381943.
39. Lipsitch, M., and, B. R. Levin. 1997. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41:363373.
40. Lipsitch, M., and, M. H. Samore. 2002. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8:347354.
41. 41. Lopez-Lozano, J. M.,, D. L. Monnet,, A. Yague,, A. Burgos,, N. Gonzalo,, P. Campillos, and, M. Saez. 2000. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int. J. Anti-microb. Agents 14:2131.
42. Lund, B.,, I. Adamsson, and, C. Edlund. 2002. Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin. Int. J. Food Microbiol. 77:109115.
43. Lund, B.,, C. Edlund,, L. Barkholt,, C. E. Nord,, M. Tvede, and, R. L. Poulsen. 2000. Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin. Scand. J. Infect. Dis. 326:627632.
44. Maisnier-Patin, S.,, O. G. Berg,, L. Liljas, and, D. I. Andersson. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46:355366.
45. Mellon, M.,, C. Benbrook, and, K. L. Benbrook. 2001. Hogging It: Estimates of Antimicrobial Abuse in Livestock. Union of Concerned Scientists, Cambridge, MA.
46. NNIS (National Nosocomial Infections Surveillance System). 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470485.
47. Noskin, G. A.,, R. J. Rubin,, J. J. Schentag,, J. Kluytmans,, E. C. Hedblom,, M. Smulders,, E. Lapetina, and, E. Gemmen. 2005. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch. Intern. Med. 165:17561761.
48. Ostrowsky, B. E.,, W. E. Trick,, A. H. Sohn,, S. B. Quirk,, S. Holt,, L. A. Carson,, B. C. Hill,, M. J. Arduino,, M. J. Kuehnert, and, W. R. Jarvis. 2001. Control of vancomycin-resistant enterococcus in health care facilities in a region. N. Engl. J. Med. 344:14271433.
49. Pittet, D.,, A. Simon,, S. Hugonnet,, C. L. Pessoa-Silva,, V. Sauvan, and, T. V. Perneger. 2004. Hand hygiene among physicians: performance, beliefs, and perceptions. Ann. Intern. Med. 141:18.
50. Rice, L. B. 2001. Emergence of vancomycin-resistant enterococci. Emerg. Infect. Dis. 7:183187.
51. Ridwan, B.,, E. Mascini,, N. van Der Reijden,, J. Verhoef, and, M. Bonten. 2002. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? Br. Med. J. 324:666668.
52. Rohr, U.,, C. Mueller,, M. Wilhelm,, G. Muhr, and, S. Gatermann. 2003. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J. Hosp. Infect. 54:305309.
53. Smith, D. L.,, J. Dushoff, and, J. G. Morris. 2005a. Agricultural antibiotics and human health. PLoS Med. 2:e232.
54. Smith, D. L.,, J. Dushoff,, E. N. Perencevich,, A. D. Harris, and, S. A. Levin. 2004. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc. Natl. Acad. Sci USA 101:37093714.
55. Smith, D. L.,, A. D. Harris,, J. A. Johnson,, E. K. Silbergeld, and, J. G. Morris, Jr. 2002. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc. Natl. Acad. Sci. USA 99:64346439.
56. Smith, D. L.,, S. A. Levin, and, R. Laxminarayan. 2005b. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc. Natl. Acad. Sci. USA 102:31533158.
57. Szajewska, H.,, M. Ruszczynski, and, A. Radzikowski. 2006. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 149:367372.
58. Verhoef, J.,, D. Beaujean,, H. Blok,, A. Baars,, A. Meyler,, C. van der Werken, and, A. Weersink. 1999. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 18:461466.
59. Witte, W. 1998. Medical consequences of antibiotic use in agriculture. Science 279:996997.
60. Wong, D.,, K. Nye, and, P. Hollis. 1991. Microbial flora on doctors’ white coats. Br. Med. J. 303:16021604.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error